Tag: James Esses
-

Puberty blocker JR stayed till July
The government’s attempt to stay James Esses, Keira Bell and the Bayswater Group’s judicial review (JR) of the Pathways Puberty Blocker trial has succeeded. There will now be an eight week pause in proceedings to give the Medicines and Healthcare products Regulatory Agency (MHRA) and King’s College London (KCL) a chance to discuss the issues…
